Action 300858 BEIJING SCITOP BIO-TECH CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Beijing Scitop Bio-tech Co., Ltd.

Actions

300858

CNE100004181

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 15/05/2024 		Varia. 5j. Varia. 1 janv.
17,12 CNY +0,82% Graphique intraday de Beijing Scitop Bio-tech Co., Ltd. -0,35% -11,30%
24/04 La société Beijing Scitop Bio-tech Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
24/04 Beijing Scitop Bio-tech Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Beijing Scitop Bio-Tech Co., Ltd. Proposes Final Dividend for the Year 2023
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Scitop Bio-tech Co., Ltd.(XSEC:300858) added to S&P Global BMI Index
Lin Wei signed a Share Transfer Agreement to acquire a 6.39% stake in Beijing Scitop Bio-tech Co., Ltd. from Sun Tiansong for approximately CNY 220 million.
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Beijing Scitop Bio-tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 27-JUL-2023.
Scitop Bio-tech Gets Patents for Four Biotechnology Inventions
Beijing Scitop Bio-Tech Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2023
Chinese Companies to Boost Research to Better Penetrate Probiotics Sector
Beijing Scitop Bio-Tech Co., Ltd. Elects Liu Huiyu, Lu Fei and Fang Fang as Independent Directors
Beijing Scitop Bio-Tech Co., Ltd. Approves Cash Dividend for 2022
Beijing Scitop Bio-Tech Co., Ltd. Announces the Profit Distribution Proposal for 2022
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Inner Mongolia Lactic Acid Bacteria Technology Research and Development Co., Ltd. announced that it expects to receive CNY 45.14 million in funding from Beijing Scitop Bio-tech Co., Ltd.
Beijing Scitop Bio-tech Co., Ltd. announced that it has received CNY 699.999976 million in funding from a group of investors
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Beijing Scitop Bio-Tech Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 29 June 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300858
  4. Actualités Beijing Scitop Bio-tech Co., Ltd.
  5. Autres langues